Bill H. Younger

COR Therapeutics, Inc.. The principal activities of the Company are the discovery, development and commercialization of novel pharmaceutical products to establish new standards of care for the treatment and prevention of severe cardiovascular diseases. Integrilin was the Company's first product taken from discovery to commercialization. A drug was approved to treat patients who undergo a procedure known as angioplasty to open blood vessels. This drug has also been approved to treat patients with intermittent chest pains known as unstable angina and patients suffering from a kind of Heart attack known as non-Q-wave myocardial infraction

Sutter Hill Ventures LLC (Sutter Hill Ventures) is a venture capital firm founded in 1962 by Paul M Wythes and Bill H Draper. The firm is headquartered in Palo Alto, California.

Vitria Technology, Inc. develops software platforms for real time e-business. It offers VIA IoT analytics platform, IoT analytics paaS, operational intelligence and businessware as products. It provides enterprise application integration software that works to integrate dissimilar software platforms and computer hardware with the Internet. The company was founded by JoMei Chang and Dale Skeen in 1994 and is headquartered in Sunnyvale, CA.

Adexa, Inc. provides enterprise business planning and performance management solutions. It offers enterprise global planning systems that provides sales, inventory, operations, demand, inventory, supply chain, and collaborative operation planning; factory planning and scheduling; and available-to-promise, supplier management, and supply chain performance management solutions. The firm also provides strategic business services that include supply chain diagnostic, supply chain network design, demand management and inventory optimization. The company was founded by Kameron Hadavi and K. Cyrus Hadavi in 1994 and is headquartered in Los Angeles, CA.

Kalypto Medical, Inc. manufactured medical devices. Its devices were used to treat diabetic leg ulcers. The firm also provided wound-care products. The company was founded in 2006 and was headquartered in Hastings, MN.

Interventional Technologies' products are helping to combat this. The company's major contributions have been in the field of microprecision fabrication techniques as applied to cardiovascular products. Some of these include: guide catheters, guide wires, microsurgical dilatation catheters, site-specific drug delivery catheters (injecting drugs, gene therapy or radio-pharmaceuticals directly into the coronary artery wall) and a photo-mask-and-etch-on-a-tube chemical milling manufacturing process for cardiovascular stents

Dextera Surgical, Inc. designs and manufactures proprietary stapling and anastomotic devices for cardiac and laparoscopic surgical procedures. It specializes in robotic-assisted surgery and medical devices. The company was founded by Bernard A. Hausen and Stephen A. Yencho on October 15, 1997 and is headquartered in Pleasanton, CA.